Clinical Setting
Recommendations for Pathology and Molecular Biomarkers
- PD-L1 22C3, PD-L1 28-8 and PD-L1 SP142
- Non-Small Cell Lung Carcinoma (NSCLC)
- Lynch Syndrome
- Colorectal Adenocarcinoma
- Breast Carcinoma
Below are excerpts from the PhenoPath Pathology Reference Guide for your convenience.
Consultative Studies
- Large cell undifferentiated malignant neoplasms
- Small, blue, round cell tumors
- Carcinomas of unknown primary site
- Mesothelioma vs. adenocarcinoma
- Spindle cell tumor/sarcoma subtyping
- Skin and mucosal immunofluorescence studies
- Hydatidiform mole evaluation
- Hematopathology diagnosis and subtyping
Organ-Restricted Studies
- Lung cancer markers
- Breast cancer markers
- Colorectal tumor prognostic and predictive markers
- GYN cancer markers
- Genitourinary tumor markers
- CNS tumor markers
Other Diagnostic Tools